The maturation of the acetylcholine system in the dentate gyrus of gerbils (Meriones unguiculatus) is affected by epigenetic factors A. BuscheA. BagordaG. Teuchert-Noodt OriginalPaper 15 June 2005 Pages: 113 - 124
Overexpression of amyloid precursor protein induces susceptibility to oxidative stress in human neuroblastoma SH-SY5Y cells K. MatsumotoY. AkaoM. Naoi OriginalPaper 15 June 2005 Pages: 125 - 135
Postnatal iron-induced motor behaviour alterations following chronic neuroleptic administration in mice A. FredrikssonP. ErikssonT. Archer OriginalPaper 05 August 2005 Pages: 137 - 150
Effects of selegiline on antioxidant systems in the nigrostriatum in rat K. TakahataS. ShimazuA. Akaike OriginalPaper 15 June 2005 Pages: 151 - 158
A new deletion in autosomal dominant guanosine triphosphate cyclohydrolase I deficiency gene – Segawa disease S. BiancaM. Bianca OriginalPaper 15 June 2005 Pages: 159 - 162
Gait analysis in patients with advanced Parkinson disease: different or additive effects on gait induced by levodopa and chronic STN stimulation S. LubikW. FogelW. H. Jost OriginalPaper 15 June 2005 Pages: 163 - 173
Motor learning of hands with auditory cue in patients with Parkinson’s disease T. ChumaM. Faruque RezaY. Mano OriginalPaper 15 June 2005 Pages: 175 - 185
[11C]d-threo-methylphenidate PET in patients with Parkinson’s disease and essential tremor S. BreitM. ReimoldU. Wüllner OriginalPaper 15 June 2005 Pages: 187 - 193
Brain perfusion SPECT in patients with mild cognitive impairment and Alzheimer’s disease: comparison of a semiquantitative and a visual evaluation W. StaffenU. SchönauerG. Ladurner OriginalPaper 15 June 2005 Pages: 195 - 203
Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer’s disease E. StefanovaA. WallA. Nordberg OriginalPaper 29 July 2005 Pages: 205 - 218
PP2B isolated from human brain preferentially dephosphorylates Ser-262 and Ser-396 of the Alzheimer disease abnormally hyperphosphorylated tau A. RahmanI. Grundke-IqbalK. Iqbal OriginalPaper 15 June 2005 Pages: 219 - 230
Polymorphism in neuropeptide Y influences CSF cholesterol levels but is no major risk factor of Alzheimer’s disease H. KölschD. LütjohannR. Heun OriginalPaper 15 June 2005 Pages: 231 - 238
Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome W. JordanS. CohrsS. Bleich OriginalPaper 15 June 2005 Pages: 239 - 254
Basal ganglia volumetric studies in affective disorder: what did we learn in the last 15 years? R. M. BonelliH.-P. KapfhammerD. A. Yurgelun-Todd Review 27 October 2005 Pages: 255 - 268